Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Ottilie

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2019
The proteasome as a target: How not tidying up can have toxic consequences for parasitic protozoaElizabeth A Winzeler, Sabine Ottilie
ACS Infectious Diseases|February 17, 2018
Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug DiscoveryMadeline R Luth, Purva Gupta, Sabine Ottilie, et al.
The FEBS Journal|February 9, 2012
Evaluation of Streptomyces coelicolor A3(2) as a heterologous expression host for the cyanobacterial protein kinase C activator lyngbyatoxin AAdam C Jones, Sabine Ottilie, Alessandra S Eustáquio, et al.
Pharmaceuticals (Basel, Switzerland)|February 8, 2020
Synthesis and Bioactivity of Phthalimide Analogs as Potential Drugs to Treat Schistosomiasis, a Neglected Disease of PovertySnigdha Singh, Nelly El-Sakkary, Danielle E Skinner, et al.
Journal of Cheminformatics|February 22, 2018
Two inhibitors of yeast plasma membrane ATPase 1 (ScPma1p): toward the development of novel antifungal therapiesSabine Ottilie, Gregory M Goldgof, Andrea L Cheung, et al.
Cell Chemical Biology|May 12, 2023
Human nuclear hormone receptor activity contributes to malaria parasite liver stage developmentNimisha Mittal, Chadwick Davis, Peter McLean, et al.
Cell Chemical Biology|December 10, 2019
Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug DiscoveryJames M Murithi, Edward S Owen, Eva S Istvan, et al.
Elife|September 22, 2023
Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistanceRebecca E K Mandt, Madeline R Luth, Mark A Tye, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 8, 2023
Development of Potent and Highly Selective Epoxyketone-Based Plasmodium Proteasome InhibitorsJehad Almaliti, Pavla Fajtová, Jaeson Calla, et al.
Science Translational Medicine|December 6, 2019
In vitro selection predicts malaria parasite resistance to dihydroorotate dehydrogenase inhibitors in a mouse infection modelRebecca E K Mandt, Maria Jose Lafuente-Monasterio, Tomoyo Sakata-Kato, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2019
The proteasome as a target: How not tidying up can have toxic consequences for parasitic protozoaElizabeth A Winzeler, Sabine Ottilie
ACS Infectious Diseases|February 17, 2018
Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug DiscoveryMadeline R Luth, Purva Gupta, Sabine Ottilie, et al.
The FEBS Journal|February 9, 2012
Evaluation of Streptomyces coelicolor A3(2) as a heterologous expression host for the cyanobacterial protein kinase C activator lyngbyatoxin AAdam C Jones, Sabine Ottilie, Alessandra S Eustáquio, et al.
Pharmaceuticals (Basel, Switzerland)|February 8, 2020
Synthesis and Bioactivity of Phthalimide Analogs as Potential Drugs to Treat Schistosomiasis, a Neglected Disease of PovertySnigdha Singh, Nelly El-Sakkary, Danielle E Skinner, et al.
Journal of Cheminformatics|February 22, 2018
Two inhibitors of yeast plasma membrane ATPase 1 (ScPma1p): toward the development of novel antifungal therapiesSabine Ottilie, Gregory M Goldgof, Andrea L Cheung, et al.
Cell Chemical Biology|May 12, 2023
Human nuclear hormone receptor activity contributes to malaria parasite liver stage developmentNimisha Mittal, Chadwick Davis, Peter McLean, et al.
Cell Chemical Biology|December 10, 2019
Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug DiscoveryJames M Murithi, Edward S Owen, Eva S Istvan, et al.
Elife|September 22, 2023
Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistanceRebecca E K Mandt, Madeline R Luth, Mark A Tye, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 8, 2023
Development of Potent and Highly Selective Epoxyketone-Based Plasmodium Proteasome InhibitorsJehad Almaliti, Pavla Fajtová, Jaeson Calla, et al.
Science Translational Medicine|December 6, 2019
In vitro selection predicts malaria parasite resistance to dihydroorotate dehydrogenase inhibitors in a mouse infection modelRebecca E K Mandt, Maria Jose Lafuente-Monasterio, Tomoyo Sakata-Kato, et al.
Pageof 4